International Edition
Latest News
Health

Chi Mei Upgrades Patient to Dual-Chamber Leadless Pacemaker After Single-Chamber Device Proves Insufficient

A 43-year-old man received a leadless dual-chamber pacemaker at Chi Mei Medical Center after his original single-chamber device proved insufficient as his heart condition deteriorated over four years. The patient was implanted with a Micra VR single-chamber leadless…

Chi Mei Upgrades Patient to Dual-Chamber Leadless Pacemaker After Single-Chamber Device Proves Insufficient

A 43-year-old man received a leadless dual-chamber pacemaker at Chi Mei Medical Center after his original single-chamber device proved insufficient as his heart condition deteriorated over four years.

The patient was implanted with a Micra VR single-chamber leadless pacemaker in 2020 for sick sinus syndrome and bradycardia, the hospital said. Subsequent development of heart failure, atrial fibrillation, atrial flutter and a transient ischemic attack prompted physicians to upgrade the system to an Aveir DR dual-chamber leadless pacemaker, according to Chi Mei Medical Center.

Cardiologist Wei-Chieh Lee said the case shows that leadless pacemakers do not remove the need for continued reassessment. “After implantation, a patient’s conduction function and rhythm status can still change over time,” Lee told Chi Mei Medical Center. “If atrioventricular block, declining cardiac function, arrhythmia, or suspected device-related discomfort appear, the original treatment strategy must be re-evaluated.”

Removing a leadless pacemaker is not a simple extraction, Lee said. Pre-procedure cardiac computed tomography confirmed the position of the original Micra device and its relationship to surrounding structures. During the procedure, the team first performed radiofrequency ablation of mitral annular atrial flutter. They then retrieved the Micra VR into a catheter sheath under guidance from an intracardiac echocardiography catheter, which confirmed no pericardial effusion during removal.

The Aveir DR system uses two leadless devices — one in the right atrium and one in the right ventricle — that communicate wirelessly to coordinate pacing. This provides atrioventricular synchrony that a single ventricular device cannot, potentially improving cardiac output in patients who develop cardiomyopathy from chronic right-ventricular pacing.

Lee emphasized that not every patient with a single-chamber leadless pacemaker requires an upgrade. “Whether to remove the old device and re-implant must be based on the patient’s conduction function, rhythm status, cardiac function and overall health, assessed by an electrophysiology team,” he said.

Wei-Chieh Lee, a cardiologist and electrophysiologist at Chi Mei Medical Center in Tainan, completed electrophysiology training at Hokkaido University Hospital in Japan and holds an M.D. from Kaohsiung Medical University and a Ph.D. from National Cheng Kung University.

He serves as Head of the Cardiac Care Unit and is an Assistant Professor at National Sun Yat-sen University, with more than 100 SCI publications in cardiac electrophysiology, pacing, and cardio-metabolic research. His honors include the TSOC Young Investigator Award in 2021 and the THRS Case Competition Award in 2025.

Lee advised patients with leadless pacemakers to seek evaluation if they experience palpitations, dyspnea, easy fatigability, reduced exercise tolerance or other new discomfort. “Do not simply attribute these to aging,” he said.

Physicians can order electrocardiography, cardiac imaging, functional assessment and device interrogation to determine whether new arrhythmias, functional decline or inadequate pacing support have developed.

Chi Mei Medical Center said it will continue to expand smart cardiovascular care and whole-person care under the “Healthy Taiwan Deep Cultivation Plan” to tailor treatment to individual needs.

About the author: Health Desk

Health Desk at Archynewsy.